Acquisition of a Hybrid Quadrupole Time of Flight LC-MS/MS System for the Cornell

为康奈尔大学采购混合四极杆飞行时间 LC-MS/MS 系统

基本信息

  • 批准号:
    8639277
  • 负责人:
  • 金额:
    $ 60万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): New mass spectrometry (MS) technologies present an exceptional opportunity for creative applications with potential for breakthrough discoveries. We request funding a high performance Q-TOF mass spectrometer (AB SCIEX TripleTOF" 5600+), interfaced with an ultra-high performance liquid chromatography system (chip-based ekspert" nanoLC 425). This state-of-the-art system will be located in the Proteomics and Mass Spectrometry Facility of the Cornell University Biotechnology Resource Center (BRC). Implementation of the instrument in the BRC as a university-wide shared research resource will enable cost effective access to this vital technology for a broad range of NIH-funded research. There is a growing demand for proteomics and mass spectrometry services at Cornell, as shown by the rapid and continuing growth in the number of facility users and samples processed by the facility over the past nine years. The proposed integrated instrument system will expand the capacity and capabilities of the facility but not duplicate the existing instrumentation at the core facility, which is currently utilized at near full capacity. The need fr increased performance and capacity is particularly critical with respect to applications involving analysis of complex samples which require enhanced scan speed, high sensitivity and resolution, and highly accurate mass measurements. The integrated system requested will provide improved dynamic range and will enable confident identification of peptides from low abundance proteins and of post-translational modifications (PTMs) in complex samples. The TripleTOF 5600+ will significantly enhance the facility's capability to support proteomics discovery studies in qualitative exploration as well as high throughput profiling and high-resolution quantification studies involving complex biological samples. The ekspert" nanoLC 425 with the cHiPLC(R) system is an integrated chip-based UHPLC that provides broad 2D LC flexibility and continuous direct nano flow. It has flexibility in workflow selection using chip-baed columns and offers a broad range of flow rates for both global discovery and higher throughput targeted quantitation. The nanoLC 425 system will provide automated sample handing and high resolution peptide separation prior to MS, which will enable continuous 24/7 analysis of very complex samples. The BRC has extensive experience in running LC MS instrument systems and providing MS applications as core facility services. The proposed instrument system will be readily integrated into the facility's established proteomics workflows and will significantly expand the facility's quantitative proteomics pipeline. Placement of the instrument system in the BRC will enable a diverse group of NIH funded investigators to undertake research projects that would not otherwise be economically or technically feasible. This proposal describes 39 projects from 16 NIH funded investigator groups that will utilize the proposed system. The requested instrument will benefit a wide range of current and future NIH-funded projects.
描述(由申请人提供):新的质谱法(MS)技术为具有突破性发现的创造性应用提供了出色的机会。我们要求为高性能质谱仪(AB Sciex Triplef“ 5600+)进行资金,并与超高性能液相色谱系统(基于芯片的EKSPERT“ Nanolc 425)相连)。该最先进的系统将位于康奈尔大学生物技术资源中心(BRC)的蛋白质组学和质谱设施中。该工具在BRC中的实施作为全大学共享的研究资源,将为广泛的NIH资助研究提供具有成本效益的这项重要技术的访问。康奈尔(Cornell)对蛋白质组学和质谱服务的需求不断增长,这表明,在过去九年中,该设施处理的设施使用者数量和样本的迅速增长和持续增长所表明。拟议的综合仪器系统将扩大设施的能力和能力,但不会复制核心设施的现有仪器,该工具目前可全额使用。对于涉及需要提高扫描速度,高灵敏度和分辨率以及高度准确质量测量值的复杂样品分析的应用,需要提高性能和能力尤为重要。所请求的集成系统将提供改进的动态范围,并能够自信地识别复杂样本中低丰度蛋白和翻译后修饰(PTMS)的肽。 5600+的三重态将显着增强该设施在定性探索中支持蛋白质组学发现研究的能力,以及涉及复杂生物样品的高吞吐量分析和高分辨率定量研究。带有Chiplc(R)系统的Ekspert“ Nanolc 425是基于芯片的集成UHPLC,可提供宽阔的2D LC灵活性和连续的直接纳米流动。它在工作流程中具有灵活性,使用芯片底线列进行了灵活的选择,并使用芯片底线提供了较高的流量,并为全球范围的发现和较高的跨性别定量提供了较高的流量。 MS将对非常复杂的样本进行连续的24/7分析。否则在经济上或技术上是不可行的。该提案描述了来自16个NIH资助的研究人员群体的39个项目,这些项目将利用拟议的系统。所请求的工具将使当前和未来的NIH资助项目受益。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The canine activated platelet secretome (CAPS): A translational model of thrombin-evoked platelet activation response.
Secreted sphingomyelins modulate low mammary cancer incidence observed in certain mammals.
  • DOI:
    10.1038/s41598-020-77639-1
  • 发表时间:
    2020-11-25
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Ledet MM;Harman RM;Fan JC;Schmitt-Matzen E;Diaz-Rubio ME;Zhang S;Van de Walle GR
  • 通讯作者:
    Van de Walle GR
Oxygen level regulates N-terminal translation elongation of selected proteins through deoxyhypusine hydroxylation.
  • DOI:
    10.1016/j.celrep.2022.110855
  • 发表时间:
    2022-05-24
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Zhang, Yugang;Su, Dan;Zhu, Julia;Wang, Miao;Zhang, Yandong;Fu, Qin;Zhang, Sheng;Lin, Hening
  • 通讯作者:
    Lin, Hening
MaXLinker: Proteome-wide Cross-link Identifications with High Specificity and Sensitivity.
MaXLinker:具有高特异性和灵敏度的全蛋白质组交联鉴定。
  • DOI:
    10.1074/mcp.tir119.001847
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yugandhar,Kumar;Wang,Ting-Yi;Leung,AldenKing-Yung;Lanz,MichaelCharles;Motorykin,Ievgen;Liang,Jin;Shayhidin,ElnurElyar;Smolka,MarcusBustamante;Zhang,Sheng;Yu,Haiyuan
  • 通讯作者:
    Yu,Haiyuan
Characterization of serum and tissue oxytocinase and tissue oxytocin in the pregnant and non-pregnant mare.
  • DOI:
    10.1038/s41598-023-31540-9
  • 发表时间:
    2023-03-21
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Diel de Amorim M;Dong L;Byron M;Foster RA;Klein C;Saleh M;Saleh T;Card C
  • 通讯作者:
    Card C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sheng Zhang其他文献

Sheng Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sheng Zhang', 18)}}的其他基金

The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10741626
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10405375
  • 财政年份:
    2021
  • 资助金额:
    $ 60万
  • 项目类别:
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10608221
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
The Roles of Huntingtin Associated Protein 40 in Huntingtin Functions and Huntington's Disease Pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10824484
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
The Roles of Huntingtin Associated Protein 40 in Huntingtin Functions and Huntington's Disease Pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10605312
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
The Roles of Huntingtin Associated Protein 40 in Huntingtin Functions and Huntington's Disease Pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10814012
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10377965
  • 财政年份:
    2019
  • 资助金额:
    $ 60万
  • 项目类别:
Convergence of tauopathy and Huntington's disease through selective autophagy
tau蛋白病和亨廷顿病通过选择性自噬的融合
  • 批准号:
    9422649
  • 财政年份:
    2017
  • 资助金额:
    $ 60万
  • 项目类别:
PROTEASE INHIBITORS USED IN THE TREATMENT OF HIV+ INDUCE BETA-CELL
用于治疗艾滋病毒的蛋白酶抑制剂诱导β细胞
  • 批准号:
    8361416
  • 财政年份:
    2011
  • 资助金额:
    $ 60万
  • 项目类别:
Functional Dissection of Huntington's Disease Protein Huntingtin Using Drosophila
使用果蝇对亨廷顿病蛋白亨廷顿蛋白进行功能解剖
  • 批准号:
    8462704
  • 财政年份:
    2010
  • 资助金额:
    $ 60万
  • 项目类别:

相似国自然基金

基于CRISPR生物技术与双传感效应的光纤传感器及其超灵敏猴痘病毒基因检测研究
  • 批准号:
    62305224
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于流感病毒结构和功能仿生基础的生物技术药物研究
  • 批准号:
    82130100
  • 批准年份:
    2021
  • 资助金额:
    291 万元
  • 项目类别:
    重点项目
生物技术启发的拓扑合成高分子制备及构效关系研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
定制工程细胞合成生物技术及多样性应用研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
下一代工业生物技术:理论与实践
  • 批准号:
    32130001
  • 批准年份:
    2021
  • 资助金额:
    291 万元
  • 项目类别:
    重点项目

相似海外基金

Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
  • 批准号:
    10596786
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
In vivo prime editing for precision cancer mouse models
精准癌症小鼠模型的体内 Prime 编辑
  • 批准号:
    10735971
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
  • 批准号:
    10598881
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
A democratized platform for mapping the spatial epigenome in tissue
用于绘制组织空间表观基因组图谱的民主化平台
  • 批准号:
    10822023
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
  • 批准号:
    10603708
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了